Śledzińska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA (2021) Prognostic and predictive biomarkers in gliomas. Int J Mol Sci 22(19):10373

Article  PubMed Central  Google Scholar 

Shahcheraghi SH, Roshani Asl E, Lotfi M, Ayatollahi J, Khaleghinejad SH, Aljabali AA et al (2024) Non-coding RNAs as key regulators of the notch signaling pathway in glioblastoma: diagnostic, prognostic, and therapeutic targets. CNS Neurol Disord Drug Targets 23(10):1203–1216

Article  Google Scholar 

Xu C, Hou P, Li X, Xiao M, Zhang Z, Li Z et al (2024) Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition. Cancer Biol Med 21(5):363–381

CAS  PubMed Central  Google Scholar 

Shahcheraghi SH, Alimardani M, Lotfi M, Lotfi M, Uversky VN, Guetchueng ST et al (2024) Advances in glioblastoma multiforme: integrating therapy and pathology perspectives. Pathol Res Pract 257:155285

Article  CAS  Google Scholar 

Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P et al (2025) Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes. Cancers 17(1):146

Article  CAS  PubMed Central  Google Scholar 

Shahcheraghi SH, Zangui M, Lotfi M, Ghayour-Mobarhan M, Ghorbani A, Jaliani HZ et al (2019) Therapeutic potential of curcumin in the treatment of glioblastoma multiforme. Curr Pharm Des 25(3):333–342

Article  CAS  Google Scholar 

Jang HJ, Park J-W (2025) Microenvironmental drivers of glioma progression. Int J Mol Sci 26(5):2108

Article  CAS  PubMed Central  Google Scholar 

Garg P, Pareek S, Kulkarni P, Horne D, Salgia R, Singhal SS (2024) Exploring the potential of tgfβ as a diagnostic marker and therapeutic target against cancer. Biochem Pharmacol 231:116646

Article  Google Scholar 

Du L, Zhu W (2024) Research progress on TGF-β gene family. Octa J Environ Res 12(4):1–10

Google Scholar 

Sheikh KA, Amjad M, Irfan MT, Anjum S, Majeed T, Riaz MU et al (2025) Exploring TGF-β signaling in cancer progression: prospects and therapeutic strategies. OncoTargets Ther 2025:233–262

Article  Google Scholar 

Golán-Cancela I, Caja L (2024) The TGF-β family in glioblastoma. Int J Mol Sci 25(2):1067

Article  PubMed Central  Google Scholar 

Yan J, Zhou X, Yang H (2024) TGF-β signaling-related signature for predicting prognosis and therapeutic response in lower-grade glioma. Transl Cancer Res 13(9):4985

Article  CAS  PubMed Central  Google Scholar 

Yang L, Pang Y (2010) TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 31(6):220–227

Article  CAS  PubMed Central  Google Scholar 

Li Z, Li M, Xia P, Wang L, Lu Z (2022) Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression. Cancer Biol Ther 23(1):225–233

Article  CAS  PubMed Central  Google Scholar 

Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113(6):685–700

Article  CAS  Google Scholar 

Kaminska B, Cyranowski S (2020) Recent advances in understanding mechanisms of TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol 1202:179–201

Article  CAS  Google Scholar 

Chen W (2023) TGF-β regulation of T cells. Ann Rev Immunol 41(1):483–512

Article  Google Scholar 

Oh SA, Li MO (2013) TGF-β: guardian of T cell function. J Immunol 191(8):3973–3979

Article  CAS  Google Scholar 

Chen B, Mu C, Zhang Z, He X, Liu X (2022) The love-hate relationship between TGF-β signaling and the immune system during development and tumorigenesis. Front Immunol 13:891268

Article  CAS  PubMed Central  Google Scholar 

Batlle E, Massagué JJI (2019) Transforming growth factor-β signaling in immunity and cancer. Immunity 50(4):924–940

Article  CAS  PubMed Central  Google Scholar 

Dahmani A, Delisle JS (2018) TGF-β in T cell biology: implications for cancer immunotherapy. Cancers 10(6):194

Article  PubMed Central  Google Scholar 

Kaminska B, Wesolowska A, Danilkiewicz M (2005) TGF beta signalling and its role in tumour pathogenesis. Acta Biochim Pol 52(2):329–337

Article  CAS  Google Scholar 

Wang P, Yu J, Yin Q, Li W, Ren X, Hao X (2012) Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway. Neurochem Res 37:2076–2084

Article  CAS  Google Scholar 

Abou Madawi NA, Darwish ZE, Omar EM (2024) Targeted gene therapy for cancer: the impact of microRNA multipotentiality. Med Oncol 41(9):214

Article  CAS  PubMed Central  Google Scholar 

Song L, Liu L, Wu Z, Li Y, Ying Z, Lin C, Wu J, Hu B, Cheng SY, Li M, Li J (2012) TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. J Clin Invest 122(10):3563–3578

Article  CAS  PubMed Central  Google Scholar 

Seoane J, Le HV, Shen L, Anderson SA, Massagué J (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117(2):211–223

Article  CAS  Google Scholar 

Chen Y, Di C, Zhang X, Wang J, Wang F, Yan JF, Xu C, Zhang J, Zhang Q, Li H, Yang H (2020) Transforming growth factor β signaling pathway: a promising therapeutic target for cancer. J Cell Physiol 235(3):1903–1914

Article  CAS  Google Scholar 

Li Z, Zhang L, Liu Z, Huang T, Wang Y, Ma Y, Fang X, He Y, Zhou Y, Huo L, Wu J (2020) miRNA-182 regulated MTSS1 inhibits proliferation and invasion in Glioma Cells. J Cancer 11(19):5840

Article  CAS  PubMed Central  Google Scholar 

Luo D, Xu X, Li J, Chen C, Chen W, Wang F, Xie Y, Li F (2018) The PDK1/c-Jun pathway activated by TGF-β induces EMT and promotes proliferation and invasion in human glioblastoma. Int J Oncol 53(5):2067–2080

CAS  Google Scholar 

Fu M, Zhang J, Zhang L, Feng Y, Fang X, Zhang J et al (2023) Cell cycle-related FAM64A could be activated by TGF-β signaling to promote glioma progression. Cell Mol Neurobiol 43(6):2975–2987

Article  CAS  PubMed Central  Google Scholar 

Xie Y, Chen L, Zhou J, Yang C, Xu C, Fan X, Tan Y, Wang Y, Kang C, Fang C (2020) TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma. Cancer Biol Med 17(3):664–675

Article  CAS  PubMed Central  Google Scholar 

Zhao K, Cui X, Wang Q, Fang C, Tan Y, Wang Y, Yi K, Yang C, You H, Shang R, Wang J (2019) RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner. Cell Death Dis 10(12):877

Article  CAS  PubMed Central  Google Scholar 

Liu L, Cheng M, Zhang T, Chen Y, Wu Y, Wang Q (2022) Mesenchymal stem cell-derived extracellular vesicles prevent glioma by blocking M2 polarization of macrophages through a miR-744–5p/TGFB1-dependent mechanism. Cell Biol Toxicol 38:1–7

Article  Google Scholar 

Liu H, Chen C, Zeng J, Zhao Z, Hu Q (2021) MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells. PLoS ONE 16(7):e0253522

Article  CAS  PubMed Central  Google Scholar 

Wang L, Lang B, Zhou Y, Ma J, Hu K (2021) Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway. Cell Cycle 20(19):1935–1952

Article  CAS  PubMed Central  Google Scholar 

Hu Y, Jiao B, Chen L, Wang M, Han X (2019) Long non-coding RNA GASL1 may inhibit the proliferation of glioma cells by inactivating the TGF-β signaling pathway. Oncol Lett 17(6):5754–5760

CAS